JP2010533478A5 - - Google Patents

Download PDF

Info

Publication number
JP2010533478A5
JP2010533478A5 JP2010516305A JP2010516305A JP2010533478A5 JP 2010533478 A5 JP2010533478 A5 JP 2010533478A5 JP 2010516305 A JP2010516305 A JP 2010516305A JP 2010516305 A JP2010516305 A JP 2010516305A JP 2010533478 A5 JP2010533478 A5 JP 2010533478A5
Authority
JP
Japan
Prior art keywords
gamma secretase
seq
ledaefrhds
lvml
substrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010516305A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010533478A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from US12/172,978 external-priority patent/US20090023158A1/en
Publication of JP2010533478A publication Critical patent/JP2010533478A/ja
Publication of JP2010533478A5 publication Critical patent/JP2010533478A5/ja
Withdrawn legal-status Critical Current

Links

JP2010516305A 2007-07-13 2008-07-14 ガンマセクレターゼの阻害剤の基質特異性を同定するための組成物および方法 Withdrawn JP2010533478A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94973807P 2007-07-13 2007-07-13
US12/172,978 US20090023158A1 (en) 2007-07-13 2008-07-14 Compositions and Methods for Identifying Substrate Specificity of Inhibitors of Gamma Secretase
PCT/US2008/070012 WO2009012237A1 (en) 2007-07-13 2008-07-14 Compositions and methods for identifying substrate specificity of inhibitors of gamma secretase

Publications (2)

Publication Number Publication Date
JP2010533478A JP2010533478A (ja) 2010-10-28
JP2010533478A5 true JP2010533478A5 (enrdf_load_stackoverflow) 2011-09-01

Family

ID=39739883

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010516305A Withdrawn JP2010533478A (ja) 2007-07-13 2008-07-14 ガンマセクレターゼの阻害剤の基質特異性を同定するための組成物および方法

Country Status (5)

Country Link
US (2) US20090023158A1 (enrdf_load_stackoverflow)
EP (1) EP2183598A1 (enrdf_load_stackoverflow)
JP (1) JP2010533478A (enrdf_load_stackoverflow)
CA (1) CA2692604A1 (enrdf_load_stackoverflow)
WO (1) WO2009012237A1 (enrdf_load_stackoverflow)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5511377B2 (ja) * 2007-06-08 2014-06-04 エーザイ・アール・アンド・ディー・マネジメント株式会社 γ−セクレターゼの新規基質EphA4を利用したスクリーニング方法
WO2009011426A1 (ja) * 2007-07-19 2009-01-22 Eisai R & D Management Co., Ltd. γ-セクレターゼの新規基質c-Metを利用したスクリーニング方法
EP2192181A4 (en) * 2007-08-01 2010-12-08 Eisai R&D Man Co Ltd SCREENING METHOD USING THE NEW C-RET SUBSTRATE FOR GAMMA-SECRETASE
US20090163594A1 (en) * 2007-10-31 2009-06-25 Elan Pharmaceuticals, Inc. Triple Assay System for Identifying Substrate Selectivity of Gamma Secretase Inhibitors
JP5580598B2 (ja) * 2007-11-15 2014-08-27 エーザイ・アール・アンド・ディー・マネジメント株式会社 γ−セクレターゼの新規基質EphA7を利用したスクリーニング方法
JP5508857B2 (ja) * 2007-11-30 2014-06-04 エーザイ・アール・アンド・ディー・マネジメント株式会社 新規活性を有するEphA4ポリペプチドおよびその用途
DK2653552T3 (en) 2010-12-17 2017-01-16 Eisai R&D Man Co Ltd SCREENING METHOD USING GELATINASE-MEDIATED EphA4 DIVISION REACTION AS INDICATOR
WO2012147798A1 (ja) 2011-04-25 2012-11-01 エーザイ・アール・アンド・ディー・マネジメント株式会社 EphA4細胞外ドメインの測定による認知機能障害を伴う神経系疾患の検出方法
DK2864496T4 (da) 2012-06-22 2021-01-04 Gentium S R L Euglobulin-baseret fremgangsmåde til bestemmelse af den biologiske aktivitet af defibrotid
EP3026122A1 (en) * 2014-11-27 2016-06-01 Gentium S.p.A. Cellular-based method for determining the potency of defibrotide
US11732260B2 (en) * 2018-03-02 2023-08-22 Ionis Pharmaceuticals, Inc. Compounds and methods for the modulation of amyloid-β precursor protein
PE20220570A1 (es) 2019-07-01 2022-04-20 Eisai Randd Man Co Ltd Anticuerpo anti-epha4 humano
US11913964B2 (en) 2020-02-27 2024-02-27 Adeptrix Corp. Multiplexed bead-based analytical assays
WO2021206910A1 (en) * 2020-04-09 2021-10-14 The Regents Of The University Of California Notch receptors with zinc finger-containing transcriptional effector
CA3189922A1 (en) 2020-07-28 2022-02-03 Ionis Pharmaceuticals, Inc. Compounds and methods for reducing app expression

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5604102A (en) * 1992-04-15 1997-02-18 Athena Neurosciences, Inc. Methods of screening for β-amyloid peptide production inhibitors
US5441870A (en) 1992-04-15 1995-08-15 Athena Neurosciences, Inc. Methods for monitoring cellular processing of β-amyloid precursor protein
US5766846A (en) * 1992-07-10 1998-06-16 Athena Neurosciences Methods of screening for compounds which inhibit soluble β-amyloid peptide production
US5605811A (en) 1992-10-26 1997-02-25 Athena Neurosciences, Inc. Methods and compositions for monitoring cellular processing of beta-amyloid precursor protein
PT730643E (pt) * 1993-10-27 2001-06-29 Lilly Co Eli Animais transgenicos portadores do alelo de app com mutacao sueca
DE10131899A1 (de) * 2001-07-04 2003-02-27 Boehringer Ingelheim Pharma In vitro-Screening-Assay für gamma-Secretase
WO2007058987A1 (en) * 2005-11-10 2007-05-24 Bristol-Myers Squibb Company Methods of identifying compounds that inhibit notch cleavage
US20090163594A1 (en) * 2007-10-31 2009-06-25 Elan Pharmaceuticals, Inc. Triple Assay System for Identifying Substrate Selectivity of Gamma Secretase Inhibitors

Similar Documents

Publication Publication Date Title
JP2010533478A5 (enrdf_load_stackoverflow)
JP2018033454A5 (enrdf_load_stackoverflow)
JP2009505964A5 (enrdf_load_stackoverflow)
JP2007508034A5 (enrdf_load_stackoverflow)
WO2017070256A8 (en) Method for screening inhibitors of ras
WO2012082056A8 (en) Novel biomarker and uses thereof in diagnosis, treatment of autism
MX2011011130A (es) Proteina o peptido de fusion con vida media in vivo incrementada mantenido por liberacion in vivo sostenida, y metodo para incrementar la vida media in vivo usando el mismo.
WO2007148224A8 (en) Polypeptide
JP2013539454A5 (enrdf_load_stackoverflow)
NZ597692A (en) Anti-IGF antibodies
JP2010519289A5 (enrdf_load_stackoverflow)
TW200634051A (en) Processes for preparing a polypeptide
JP2013505287A5 (enrdf_load_stackoverflow)
WO2009079212A3 (en) Linked peptide fluorogenic biosensors
WO2009024327A3 (en) New proteins for use in human and animal staphylococcus infections
JP2009527503A5 (enrdf_load_stackoverflow)
WO2005119251A3 (en) Novel means and methods for the treatment of hearing loss and phantom hearing
WO2018175581A8 (en) A GENETICALLY MODIFIED MOUSE EXPRESSING HUMAN APOE4 AND MOUSE Trem2 p.R47H AND METHODS OF USE THEREOF
WO2009107971A3 (ko) 포스파티딜세린과 특이적으로 결합하는 폴리펩티드 및 이의 용도
JP2005512547A5 (enrdf_load_stackoverflow)
WO2008142664A3 (en) Exposed thymidine kinase 1 peptides, ligands and methods employing the same
ATE488252T1 (de) Erhöhte transduktion mit abc- transportersubstratenhemmern
EA200801856A1 (ru) Система привода для манипулятора (варианты)
JP2014534173A5 (enrdf_load_stackoverflow)
WO2008126783A1 (ja) ジペプチドの製造法